Dr. Nitasha Sarswat and Dr. C. Michael Gibson discuss datapresented at ACC 2025: Acoramidis-Mediated Early Increase in Serum Transthyretin Level Reduces Cardiovascular-Related Hospitalizations and Mortality: Insights From The Attribute-CM Study
Disclosures: Sponsored by BridgeBio Pharma, Inc